Literature DB >> 26408927

Tissue Factor: Old and New Links with Cancer Biology.

Henri H Versteeg1.   

Abstract

Blood coagulation is one of the most profound factors that influence cancer progression. Especially the initiator of coagulation, tissue factor (TF), has been subject to many studies investigating the overlap between coagulation and cancer. It has been known for decades that TF is a risk factor for metastasis, and in mouse models, TF drives metastasis in a coagulation-dependent manner. However, TF also serves as a cellular receptor to drive primary tumor growth and tumor angiogenesis. Nevertheless, recent studies have indicated that TF plays more fundamental roles in cancer biology. TF regulates tumor cell dormancy, is associated with cancer stem cell behavior, epithelial-to-mesenchymal transition, and dictates establishment of the tumor cell premetastatic niche. Especially with regard to these recent roles attributed to TF, no clear idea exists on the exact molecular pathways that are initiated by TF. Finally, TF alternative splicing results in an isoform with different characteristics and functions in cancer. In this review, a summary will be given on both the established as well as the new aspects of TF function in cancer progression. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26408927     DOI: 10.1055/s-0035-1556048

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


  8 in total

1.  Crosstalk between TF/FVIIa and EGFR signaling in colorectal cancer cells.

Authors:  He-Kai Chen; Xin Wang; Yuan-Lian Wan; Jian-Qiang Tang
Journal:  Cancer Biol Ther       Date:  2018-11-21       Impact factor: 4.742

2.  Platelet-Derived PDGFB Promotes Recruitment of Cancer-Associated Fibroblasts, Deposition of Extracellular Matrix and Tgfβ Signaling in the Tumor Microenvironment.

Authors:  Yanyu Zhang; Ehsan Manouchehri Doulabi; Melanie Herre; Jessica Cedervall; Qi Qiao; Zuoxiu Miao; Anahita Hamidi; Lars Hellman; Masood Kamali-Moghaddam; Anna-Karin Olsson
Journal:  Cancers (Basel)       Date:  2022-04-12       Impact factor: 6.575

3.  Functional impairment of activated protein C in breast cancer - relationship to survival outcomes.

Authors:  Mario Roselli; Patrizia Ferroni; Silvia Riondino; Sabrina Mariotti; Ilaria Portarena; Jhessica Alessandroni; Cristiano Ialongo; Renato Massoud; Leopoldo Costarelli; Francesco Cavaliere; Sergio Bernardini; Fiorella Guadagni
Journal:  Am J Cancer Res       Date:  2016-06-01       Impact factor: 6.166

4.  Deletion of Glutathione S-Transferase Omega 1 Activates Type I Interferon Genes and Downregulates Tissue Factor.

Authors:  Yibin Xu; Armand Bankhead; Xiaoli Tian; Jianming Tang; Mats Ljungman; Nouri Neamati
Journal:  Cancer Res       Date:  2020-06-22       Impact factor: 13.312

Review 5.  Cancer and Thrombosis: The Platelet Perspective.

Authors:  Claire K S Meikle; Clare A Kelly; Priyanka Garg; Leah M Wuescher; Ramadan A Ali; Randall G Worth
Journal:  Front Cell Dev Biol       Date:  2017-01-05

Review 6.  Thromboembolism in Patients with Bladder Cancer: Incidence, Risk Factors and Prevention.

Authors:  Piotr Zareba; Wilhelmina C M Duivenvoorden; Jehonathan H Pinthus
Journal:  Bladder Cancer       Date:  2018-04-26

7.  Pathological expression of tissue factor confers promising antitumor response to a novel therapeutic antibody SC1 in triple negative breast cancer and pancreatic adenocarcinoma.

Authors:  Xuesai Zhang; Qingrou Li; Hui Zhao; Lanping Ma; Tao Meng; Jianchang Qian; Rui Jin; Jingkang Shen; Ker Yu
Journal:  Oncotarget       Date:  2017-07-10

Review 8.  Platelets, Constant and Cooperative Companions of Sessile and Disseminating Tumor Cells, Crucially Contribute to the Tumor Microenvironment.

Authors:  Wolfgang M J Obermann; Katrin Brockhaus; Johannes A Eble
Journal:  Front Cell Dev Biol       Date:  2021-04-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.